A Popular Hot Sauce Has Been Recalled in 10 States for Potential ‘Life-Threatening' Allergic Reaction
Spicy food lovers may need to double check the condiments in their fridges before the next taco night.
On Thursday, April 3, T.W. Garner Food Company issued a recall for sulfite contamination in select bottles of its popular hot sauce brand, Texas Pete.
According to the release published by the Food and Drug Administration (FDA), the contaminated products may contain Sriracha Sauce, which contains sulfites.
Related: Chocolate Bars Recalled for Potentially Containing 'Small Stones'
While these food preservatives are generally safe, those who are allergic to sulfites can experience potentially life-threatening side effects. These include but are not limited to an asthma attack, coughing, sneezing, hives, and in more severe (yet rare) cases, anaphylaxis and vomiting, per the Cleveland Clinic.
The products in the report include the Texas Pete Habanero Buffalo Sauce in two fluid-ounce and 12 fluid-ounce containers, with best buy dates listed as Dec. 12, 2025, and Nov. 7, 2025, respectively.
Also included in the recall are various sizes of Texas Pete Sweet CHAbanero Sweet Sriracha Habanero Sauce due to the ingredients label not including Aged Peppers.
Related: Recall Issued for Over 22,000 Pounds of This Popular Sausage Due to Foreign Matter Contamination
Of this flavor, the two fluid-ounce containers with MFR codes BB 090427M and BB 082627M, as well as the 20 fluid-ounce and half-gallon containers — best buy dates listed as Aug. 2, 2027, and July 23, 2027, respectively — are also included in the report.
The states that received the contaminated products are California, Colorado, Connecticut, Illinois, Massachusetts, North Carolina, New Jersey, Ohio, Virginia, and Vermont.
The contaminated products were delivered to retailers between Feb. 5, 2025, and March 26, 2025. No illnesses have been reported to date, however, consumers who have received the aforementioned impacted products are encouraged not to consume and to dispose of the product immediately. Consumers can also return the product to the place of purchase for a full refund.
For further assistance, buyers can contact the Director of Quality Assurance, Katerine Cardoso, via email at contactus@garnerfoods.com.
This is just another recall that's already occurred this year thus far. Other recalls this year have included ground coffee from Massimo Zanetti Beverage USA, dark chocolate products from Cal Yee Farms, baked goods from one of Dunkin's vendors, a cheese from Aldi and Coca-Cola soda packs.
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
Lawmakers urge Trump administration to clamp down on illicit GLP-1 sales
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing these drugs without knowing the product could be fraudulent. North Carolina Reps. Brad Knott (R) and Deborah Ross (D) wrote to Food and Drug Administration (FDA) Commissioner Marty Makary, Homeland Security Secretary Kristi Noem and U.S. Attorney General Pam Bondi, imploring them to end the sale of 'counterfeit, research-grade and illegal copycats' of popular GLP-1 medications. When the commercial, branded versions of tirzepatide and semaglutide were declared to no longer be in shortage, compounding pharmacies were disallowed from continuing to sell compounded versions of those drugs. While telehealth companies have transitioned away from compounded versions, state officials have warned that 'copycat' drugs have proliferated in the months since the shortages ended. Earlier this year, the National Association of Attorneys General sent a letter to the FDA to warn that 'counterfeit GLP-1 drugs have infiltrated the U.S. supply chain from China, Turkey, India, and other foreign sources.' According to the attorneys general, online retailers sell the active ingredient for the GLP-1s under the claim that they're 'for research purposes only' or 'not for human consumption' while still marketing them to consumers on social media. The FDA issued a warning in April, telling consumers to not take counterfeit Ozempic. The drug's manufacturer, Novo Nordisk, had alerted the agency that several hundred units of counterfeit product had entered the U.S. supply chain. At the time, the FDA said it was aware of six adverse events associated with the counterfeit products. Though the FBI issued a public service warning soon after the letter from the attorneys general was sent, Knott and Ross said raising public awareness wasn't enough. 'FDA has received hundreds of reports of adverse events, even some resulting in the hospitalization and death of patients who used illicit GLP-1s,' they wrote. 'This is likely a significant underreporting of adverse events experienced by patients because federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events to FDA.' The lawmakers asked that the Trump Cabinet members fully use 'the legal tools at your discretion' to further detect illicit and enforce U.S. drug standards. Sen. Thom Tillis (R-N.C.) sent his own letter to Cabinet members, calling for enhanced collaboration among agencies like FDA, U.S. Customs and Border Protection and the Justice Department in order to stop the counterfeit products from reaching the supply chain in the first place. The Hill has reached out to the agencies named in the letter for comment.
Gizmodo
6 hours ago
- Gizmodo
After Slashing Thousands of Jobs, Trump's FDA Wants to Use AI to Rapidly Approve New Drugs
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according to a newly released paper, its top brass now wants to use automation to more 'efficiently' approve new drugs. An article recently published in the Journal of the American Medical Association (JAMA) by Dr. Vinay Prasad, the FDA's director of a subagency that deals with vaccines, lays out a vision for revamping the agency that will supposedly 'increase efficiency' at the agency that regulates what you eat and drink. According to that article, a big way to make the agency more efficient is to use AI to do tasks that humans previously worked on. Specifically, it suggests using automation to speed up the drug approval process. 'The advent of generative artificial intelligence (AI) holds several promises to modernize the FDA and radically increase efficiency in the review process,' the paper reads, while noting that the agency has already implemented a pilot program that involves first 'AI-assisted scientific review.' The article also speaks of a need to 'reevaluate legacy processes at the agency that slow down decisions and do not increase safety.' The study also claims it is looking to find ways to use technology to avoid 'animal cruelty' at the agency. It has supposedly done this by developing 'a road map to reduce animal testing using AI-based computational modeling to predict toxicity-leveraging chip technology.' All of this news comes not long after the FDA purged thousands of staffers from its ranks, including those responsible for reviewing food safety. Now, in what has become a typical pivot for organizations looking to integrate AI, roles previously held by humans seem like they're being automated. The article also suggests the use of 'big data' to help better assess how drug products are developed and reviewed. 'In the past, randomized clinical trials were the sole method used to determine if a product was safe and effective,' the article reads. 'Advances in causal inference in nonrandomized data, including the use of target trials, which attempt to balance confounding and time zero, have [the] potential to yield actionable causal conclusions, in many cases at lower cost.' AI has been spread throughout other parts of the government, as the administration's supposed 'efficiency' mandate looks for newfangled methods to 'streamline' bureaucratic processes. If AI could technically help speed up some bureaucratic processes, a quick look at the way automation rollout is being handled at other agencies doesn't necessarily inspire confidence in the initiative, particularly when it comes to an agency tasked with overseeing drugs that go into Americans' bodies. When it comes to new drugs, there are always guinea pigs involved in the process; now AI's impact will have to be factored into the effectiveness of the latest tests.
New York Post
9 hours ago
- New York Post
Why wearing a tampon while working out may not be great for your health
No sweat! Experts say exercising on your period is absolutely fine — and even beneficial — because hitting the gym can reduce menstrual pain, boost mood and potentially ease bloating. If you're planning to embrace outdoor workouts this summer, you may want to take extra care choosing feminine products that offer protection while also helping to manage sweat, odor and chafing. Advertisement 4 Hitting the gym can reduce menstrual pain, boost mood and potentially ease bloating. Getty Images/iStockphoto Though it is generally safe to exercise while wearing a tampon, the founder and CEO of the nontoxic, sustainable period care brand Viv For Your V warns of a possible hygiene issue with sweaty, high-impact activity. 'Sweat tends to accumulate around the vagina and underwear, creating a damp environment, causing the tampon string to become wet,' Katie Diasti told The Post. 'A wet string can lead to an increase in bacterial growth and higher risk of UTIs and yeast infections.' Advertisement Pads, menstrual cups, discs or athletic period underwear may be better options. For their part, tampons have come under fire recently due to concerns about their safety and potential health risks. A shocking 2024 study found lead, arsenic and other toxic heavy metals in several tampon brands, prompting an investigation by the Food and Drug Administration. 4 Though it is generally safe to exercise while wearing a tampon, one menstrual brand CEO warns of a potential hygiene issue with sweaty, high-impact activity. Pixel-Shot – Advertisement The agency's initial literature review didn't identify safety concerns with tampon use and contaminant exposure. The FDA is also conducting laboratory tests to determine if metals are released from tampon materials into the body. Dr. Alessandra Hirsch, an OB/GYN at NewYork-Presbyterian/Columbia University Irving Medical Center, pointed out that the 2024 study didn't explore whether the metals were absorbed through the vaginal lining. Advertisement 'A substance is only 'toxic' if it reaches vital organs in a high enough quantity to cause harm, which this paper did not investigate,' Hirsch told The Post. 'The American College of Medical Toxicology released a statement last year in response to this paper to reassure menstruating individuals that there is still no evidence that tampons cause metal poisoning.' 4 A shocking 2024 study found lead, arsenic and other toxic heavy metals in several tampon brands, prompting an investigation by the Food and Drug Administration. ¿¿¿¿¿ ¿¿¿¿¿¿¿¿ – As its investigation carries on, the FDA 'continues to recommend FDA-cleared tampons as a safe option' for menstrual use. 'Much more study and research is required, and there are currently no recommendations to not use tampons,' Dr. Mitchell Kramer, director of obstetrical and gynecologic strategy and clinical integration at Northwell's Huntington Hospital, told The Post. 'There are certain ways to minimize risk,' he added. 'Use 100% organic cotton tampons that do not contain any dyes or fragrances, avoid synthetic fiber tampons, change tampons frequently (this also minimizes the risk of toxic shock syndrome), and use tampons for the minimum amount of time that is comfortable during the period.' Toxic shock syndrome (TSS) is a rare but potentially life-threatening illness caused by bacterial toxins. Advertisement A tampon left in too long can become a breeding ground for bacteria that cause TSS, bacterial vaginosis and vaginal yeast infections. 4 This summer, you should take extra care choosing feminine products that offer protection while also helping to manage sweat, odor and chafing. zakalinka – The FDA recommends changing tampons every four to eight hours to maintain good hygiene and reduce the risk of bacterial growth and TSS. Advertisement That's why tampons might not be the best choice while sleeping, hiking and playing outside for a long time, Diasti said. 'These situations can make it harder to change your tampon on time,' she added. 'Menstrual cups and discs are great alternatives — they offer longer wear time and greater convenience for extended periods without access to a restroom.' Menstrual discs are designed to sit in the space behind the cervix, while menstrual cups are typically positioned just below the cervix. The cup must fit well. Diasti said a wrong-fitting cup can leak or shift during physical activity, especially for those with a high or low cervix. Advertisement Hirsch warns that an improperly cleaned menstrual cup may increase the risk of fungal infections, while pads or period underwear can cause local allergic reactions such as rashes and itching. 'All of this is to say that, unfortunately, manufactured products all carry some unknown risk, which we believe to be quite small,' Hirsch said. 'For now, the best way to decide on a period product is to pick the best fit for your lifestyle.' If none of these options work for you, there's always free bleeding.
